Paul Compton and his wife Andrea chose to start a family through adoption. Unknown to anyone, one of their adopted boys, Taeson, was the inheritor of DRPLA, a progressive brain disorder caused by a mutation in the ATN1 gene. Determined to find a treatment and advocate for their son and others with the disease, the Comptons established CureDRPLA. In early 2024, Taeson received his initial treatment with an ASO discovered and developed by n-Lorem. Paul discusses his family’s journey and shares his observations of Taeson's progress since beginning treatment.

In This Episode We Discuss:

3:05 – Paul's origins in business and finance 

4:32 - Investment banking is different than traditional banking 

7:27 – Opposites attract – Meeting his wife, Andrea, and starting a family through adoption 

10:06 – Paul’s son, Tayson, has a progressive brain disorder known as DRPLA, which is caused by a mutation in the ATN1 gene; Discovering the idea of n-Lorem 

16:03 – Tayson’s journey to a diagnosis 

23:00 – The deterioration of his abilities over the years 

25:00 – The progress Paul has observed in his son since initial treatment 

Links:

Take our survey and receive an n-Lorem Store coupon code

Register for the 2024 Nano-rare Patient Colloquium / October 30-31, 2024

Make Hope Possible with a donation